Skip to main content

Featured

  Landlord Corner | Canadian Money Brief N12 Own-Use Notice: 60 Days Plus a Month's Rent, or 120 Days and Nothing? Week of Monday, November 23, 2026 • Ontario Residential Tenancies Act If you plan to move into your own rental unit, or move in a close family member, the N12 is the notice you serve. Since September 21, 2026, you have a choice that did not exist before: give 60 days and pay the tenant one month's rent, or give 120 days and pay nothing. The catch is in the date, and a wrong date can sink the whole notice. The Two Routes 60-day notice 120-day notice Minimum notice 60 days 120 days Termination date Last day of a rental period or fixed term Same: last day of a rental period or fixed term Compensation One month's rent, or another unit the tenant accepts, paid by the termination date None owed Applies to Own use, and purchaser's own use Landlord's own use only, notices served on or after Sept 21, 2026 A purchaser's-own-use N12 still owes compensation, ...

article

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Comments